- Home
- SRL vs MNOV Comparison
SRL vs MNOV Comparison
Compare SRL & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRL | MNOV |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0M | 72.7M |
| IPO Year | 1996 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SRL | MNOV |
|---|---|---|
| Price | $9.54 | $1.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 38.7K | ★ 64.8K |
| Earning Date | 01-01-0001 | 06-06-2026 |
| Dividend Yield | ★ 11.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $5.13 | $1.13 |
| 52 Week High | $10.39 | $1.96 |
Technical Indicators
Market Signals| Indicator | SRL | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 49.82 |
| Support Level | $9.28 | $1.55 |
| Resistance Level | $10.39 | $1.69 |
| Average True Range (ATR) | 0.41 | 0.08 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 37.27 | 36.36 |
Price Performance
Historical ComparisonAbout SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.